As GLP-1 medications like Ozempic soar in popularity, our new documentary follows three people on their weight-loss journeys ...
As revolutionary new weight-loss drugs turn consumers off ultraprocessed foods, the industry is on the hunt for new products.
President-elect Donald J. Trump is set to nominate Robert F. Kennedy Jr. to lead the Health and Human Services Department, ...
Jamie Chung for The New York Times Supported by By Tomas Weber Trinian ... Auerbach was trying to understand the shopping behavior of Ozempic users, and Taylor was one of her case studies.
New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...
The rise of GLP-1 drugs like Ozempic and Wegovy are transforming the food industry, and with over seven million Americans ...
If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump ...
The costly proposal from the US Department of Health and Human Services sets the stage for a potential showdown between the powerful pharmaceutical industry and Robert F. Kennedy Jr., an ...
Millions of Americans with obesity could soon gain access to popular weight-loss drugs including Wegovy and Ozempic through Medicare and Medicaid under a new proposal from the Biden administration.